Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "therapies"

1633 News Found

Pfizer scores landmark EU approval for  hemophilia drug HYMPAVZI
Drug Approval | May 14, 2026

Pfizer scores landmark EU approval for hemophilia drug HYMPAVZI

The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy


AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
interviews | May 13, 2026

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution


Vyome secures exclusive license from Impetis for selective JAK inhibitor programs
News | May 13, 2026

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs

The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments


Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC
People | May 13, 2026

Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC

Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets


Agilent and Veeda collaborate to strengthen regulatory-ready biopharma analytics
Biopharma | May 13, 2026

Agilent and Veeda collaborate to strengthen regulatory-ready biopharma analytics

The two companies will establish a joint Center of Excellence (CoE) in Bengaluru


NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs
R&D | May 12, 2026

NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs

In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike


CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge
News | May 12, 2026

CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge

The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market


From lab bench to market: Strengthening translational research in India’s biotech ecosystem
Opinion | May 11, 2026

From lab bench to market: Strengthening translational research in India’s biotech ecosystem

India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells


Dr. Reddy’s and Nestle Health Science launch Celevida GLP for optimized nutritional support
Healthcare | May 08, 2026

Dr. Reddy’s and Nestle Health Science launch Celevida GLP for optimized nutritional support

Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass